IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Adamant Biomedical Investments AG

Portfolio Profile

CIK: 0001542336 | Zurich, V8

$39.1M
AUM
101
Positions
99.2%
Top 10 Conc.
99.53%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Biogen Idec Inc(BIIB)53,250$18.1M46.20%
2Acadia Pharmaceuticals Inc(ACAD)205,000$6.5M16.64%
3Brookdale Senior Living Inc(BKD)129,540$4.8M12.14%
4Abbvie Inc(ABBV)60,000$3.9M10.03%
5Biomarin Pharmaceutical Inc(BMRN)36,000$3.3M8.32%
6Alnylam Pharmaceuticals Inc(ALNY)23,000$2.2M5.70%
7Celgene Corporation(CELG)186,170$20.8K0.05%
8Gilead Sciences Inc(GILD)180,390$17.0K0.04%
9Amgen Inc(AMGN)95,000$15.1K0.04%
10Actavis PLC51,590$13.3K0.03%

Sector Allocation

Latest filing, equity positions only

Healthcare99.48% · $38.9M
Unclassified0.52% · $203.2K

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare99.33%99.48%+0.15%
Unclassified0.67%0.52%-0.15%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$29.3M | 96 pos.
$39.1M | 101 pos.
Q3
14
Q4
14

Recent Activity

Quarter-over-quarter position changes

13
New
8
Closed
10
Increased
34
Decreased
Cap SizePrev %Curr %Change
Large Cap81.1%60.56%-20.54%
Mid Cap18.15%28.82%+10.67%
Mega Cap0.08%10.09%+10.01%
Unclassified0.67%0.52%-0.15%
Small Cap0%0%0%
44
Unchanged